VERICEL CORPORATION Restricted Cash
VERICEL CORPORATION (VCEL) had Restricted Cash of $43.00 million as of 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-08-02
- 2023-06-30: Restricted Cash $43.00M.
- 2021-09-30: Restricted Cash $211.00K.
- 2021-06-30: Restricted Cash $211.00K.
- 2021-03-31: Restricted Cash $211.00K.
| Period end | Restricted Cash | Restricted Cash as first filed |
|---|---|---|
| 2023-06-30 | $43.00M 10-Q · filed 2023-08-02 | |
| 2021-09-30 | $211.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $211.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $211.00K 10-Q · filed 2021-05-05 | |
| 2020-09-30 | $211.00K 10-Q · filed 2021-11-09 | $200.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $89.00K 10-Q · filed 2021-08-04 | $100.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $89.00K 10-Q · filed 2021-05-05 | $100.00K 10-Q · filed 2020-05-11 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |